deVGen NV
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 37 (Table of Contents)
Published: 3 Jun-2003
DOI: 10.3833/pdr.v2003.i37.898 ISSN: 1756-7874
Section: Company Profile
Fulltext:
Abstract
DevGen is a biotechnology company that focuses on in vivo drug discovery based on the use of the model organism Caenorhabditis elegans, a small nematode that helps in deeper understanding of human disease and new concepts for therapeutic intervention...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018